MX2010009732A - Processes for preparing enantiomerically pure diol and dioxolane compounds. - Google Patents

Processes for preparing enantiomerically pure diol and dioxolane compounds.

Info

Publication number
MX2010009732A
MX2010009732A MX2010009732A MX2010009732A MX2010009732A MX 2010009732 A MX2010009732 A MX 2010009732A MX 2010009732 A MX2010009732 A MX 2010009732A MX 2010009732 A MX2010009732 A MX 2010009732A MX 2010009732 A MX2010009732 A MX 2010009732A
Authority
MX
Mexico
Prior art keywords
enantiomerically pure
processes
pure diol
preparing enantiomerically
dioxolane compounds
Prior art date
Application number
MX2010009732A
Other languages
Spanish (es)
Inventor
Partha Barnerjee
Original Assignee
Stiefel Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stiefel Laboratories filed Critical Stiefel Laboratories
Publication of MX2010009732A publication Critical patent/MX2010009732A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Abstract

The present invention relates to novel processes for preparing enantiomerically pure diol and dioxolane compounds from racemic starting materials and the use of these compounds for preparing therapeutically active agents.
MX2010009732A 2008-03-03 2009-03-02 Processes for preparing enantiomerically pure diol and dioxolane compounds. MX2010009732A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US3326608P 2008-03-03 2008-03-03
PCT/US2009/001315 WO2009114080A2 (en) 2008-03-03 2009-03-02 Processes for preparing enantiomerically pure diol and dioxolane compounds

Publications (1)

Publication Number Publication Date
MX2010009732A true MX2010009732A (en) 2010-09-30

Family

ID=41065699

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010009732A MX2010009732A (en) 2008-03-03 2009-03-02 Processes for preparing enantiomerically pure diol and dioxolane compounds.

Country Status (7)

Country Link
EP (1) EP2255009A4 (en)
JP (1) JP2011513398A (en)
CN (1) CN102015582A (en)
AU (1) AU2009223833A1 (en)
CA (1) CA2718166A1 (en)
MX (1) MX2010009732A (en)
WO (1) WO2009114080A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102234267A (en) * 2010-04-21 2011-11-09 中国科学院上海药物研究所 Novel triazole antifungal compounds, and medicinal composition, preparation method and application thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5661151A (en) * 1993-12-21 1997-08-26 Schering Corporation Tetrahydrofuran antifungals
TW593312B (en) * 1997-07-11 2004-06-21 Janssen Pharmaceutica Nv 2,4,4-trisubstituted-1,3-dioxolane antifungals
ES2360096T3 (en) * 2002-08-06 2011-05-31 Pharmasset, Inc. PREPARATION PROCEDURES FOR 1,3-DIOXOLAN NUCLEOSIDS.
US7585881B2 (en) * 2004-02-18 2009-09-08 Astrazeneca Ab Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists

Also Published As

Publication number Publication date
WO2009114080A2 (en) 2009-09-17
EP2255009A2 (en) 2010-12-01
CN102015582A (en) 2011-04-13
CA2718166A1 (en) 2009-09-17
WO2009114080A3 (en) 2010-03-04
JP2011513398A (en) 2011-04-28
EP2255009A4 (en) 2011-08-10
AU2009223833A1 (en) 2009-09-17

Similar Documents

Publication Publication Date Title
UA110197C2 (en) To novel compounds which are effective as an inhibitor for xanthine oxidase, a process for preparing the same, and a pharmaceutical composition comprising a therapeutically effective amount of the same
MX2011009369A (en) Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators.
IL238337A (en) Process for the manufacture of pharmaceutically active compounds
WO2009118107A3 (en) Skin care composition
MX2010012298A (en) Glucokinase activators.
MY150542A (en) Cmet inhibitors
EP3699176A3 (en) Antiviral compounds
MX2020011251A (en) Antiviral compounds.
TW200626068A (en) Active compounds for seed treatment
UA116809C2 (en) APPLICATION OF AGROCHEMICAL MIXTURES FOR INCREASING THE VITALITY OF THE PLANT
MX2011008825A (en) Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators.
MX2012002641A (en) Inhibitors of jak.
MX2011012533A (en) Spiro epoxides as intermediates.
MX2011008662A (en) Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators.
MX2011009338A (en) Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators.
MX2012007341A (en) Proteasome inhibitors and processes for their preparation, purification and use.
MX2010009931A (en) Process for the preparation of 2-amino-2- [2- (4-c3-c21-alkyl-phenyl)ethyl] propane-1, 3-diols.
MX2012007834A (en) Carboxylic acid derivatives having a 2,5-substituted oxazolopyrimidine ring.
WO2010059916A3 (en) Preparation of docetaxel
MX2010009732A (en) Processes for preparing enantiomerically pure diol and dioxolane compounds.
SI2293791T1 (en) Pharmaceutical compositions of entacapone co-micronized with sugar alcohols
WO2013072766A3 (en) Process for cabazitaxel and intermediates thereof
MX2013002656A (en) New process.
MX2010003056A (en) Valomaciclovir polymorphs.
TN2010000527A1 (en) Glucokinase activators

Legal Events

Date Code Title Description
FA Abandonment or withdrawal